论文部分内容阅读
Objective To study the changes of biomarkers in cerebrospinal fluid (CSF) in cerebral amyloidangiopathy (CAA) dementia and Alzheimer's disease.Methods Levels of amyloid protein β (Aβ42, Aβ40) and phosphorylated Tau-protein (P-tau) in CSFand ratio of Aβ42/